Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Goodwill Amortization of Goodwill Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Repurchased Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Cabot (CBT) Asset Writedowns and Impairment (2009 - 2021)

Cabot (CBT) reported Asset Writedowns and Impairment of $197.0 million for Q4 2021, up 19600.0% on a QoQ basis from $1.0 million in Q1 2020.

Cabot (CBT) has 9 years of Asset Writedowns and Impairment data on file, last reported at $197.0 million in Q4 2021.

Quarterly Asset Writedowns and Impairment changed N/A year-over-year to $197.0 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $218.0 million (changed N/A YoY) and the FY2018 annual result came in at $162.0 million, changed N/A from the prior year.
Asset Writedowns and Impairment climbed to $197.0 million in Q4 2021 per CBT's latest filing, from $1.0 million in the prior quarter.
Across five years, Asset Writedowns and Impairment topped out at $197.0 million in Q4 2021 and bottomed at $1.0 million in Q1 2020.
The 4-year median for Asset Writedowns and Impairment is $91.0 million (2018), against an average of $95.0 million.
The widest annual swing landed in 2019, when Asset Writedowns and Impairment slumped 87.65%; it then tumbled 95.0% in 2020.
Tracing CBT's Asset Writedowns and Impairment over 4 years: stood at $162.0 million in 2018, then tumbled by 87.65% to $20.0 million in 2019, then plunged by 95.0% to $1.0 million in 2020, then soared by 19600.0% to $197.0 million in 2021.
Per Business Quant, the three latest CBT Asset Writedowns and Impairment figures stand at $197.0 million (Q4 2021), $1.0 million (Q1 2020), and $20.0 million (Q1 2019).

Historic Data

Download Data 🔒

Date	Value
Dec 31, 2021	197.00 Mn
Dec 31, 2021	197.00 Mn
Mar 31, 2020	1.00 Mn
Mar 31, 2020	1.00 Mn
Mar 31, 2019	20.00 Mn
Mar 31, 2019	20.00 Mn
Mar 31, 2018	162.00 Mn
Mar 31, 2018	162.00 Mn
Dec 31, 2015	23.00 Mn
Dec 31, 2015	23.00 Mn
Sep 30, 2015	1.00 Mn
Sep 30, 2015	1.00 Mn
Jun 30, 2015	209.00 Mn
Jun 30, 2015	209.00 Mn
Dec 31, 2014	1.00 Mn
Dec 31, 2014	1.00 Mn
Jun 30, 2014	1.00 Mn
Jun 30, 2014	1.00 Mn
Dec 31, 2013	3.00 Mn
Dec 31, 2013	3.00 Mn
Jun 30, 2013	-1.00 Mn
Jun 30, 2013	-1.00 Mn
Sep 30, 2011	-1.00 Mn
Sep 30, 2011	-1.00 Mn
Jun 30, 2011	1.00 Mn
Jun 30, 2011	1.00 Mn
Dec 31, 2009	2.00 Mn
Dec 31, 2009	2.00 Mn